Global RNAi for Therapeutic Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 01-Jan-2020
No. of pages: 90
Inquire Before Buying

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.

Market Analysis and Insights: Global RNAi for Therapeutic Market

In 2019, the global RNAi for Therapeutic market size was US$ 1521.7 million and it is expected to reach US$ 6616.2 million by the end of 2026, with a CAGR of 23.1% during 2021-2026.

Global RNAi for Therapeutic Scope and Market Size

RNAi for Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global RNAi for Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the RNAi for Therapeutic market is segmented into siRNA, miRNA, shRNA, etc.

Segment by Application, the RNAi for Therapeutic market is segmented into Cancer, Cardiovascular, HBV, Other, etc.

Regional and Country-level Analysis

The RNAi for Therapeutic market is analysed and market size information is provided by regions (countries).

The key regions covered in the RNAi for Therapeutic market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape and RNAi for Therapeutic Market Share Analysis

RNAi for Therapeutic market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in RNAi for Therapeutic business, the date to enter into the RNAi for Therapeutic market, RNAi for Therapeutic product introduction, recent developments, etc.

The major vendors include Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, Quark Pharmaceuticals, RXi Pharmaceuticals, Silence Therapeutics, Benitec Biopharma, miRagen Therapeutics, Sylentis, Gradalis, Sirnaomics, Silenseed, etc.

This report focuses on the global RNAi for Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNAi for Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Alnylam Pharmaceuticals

- Arbutus Biopharma (Tekmira)

- Arrowhead

- Dicerna Pharmaceuticals

- Mirna Therapeutics

- Quark Pharmaceuticals

- RXi Pharmaceuticals

- Silence Therapeutics

- Benitec Biopharma

- miRagen Therapeutics

- Sylentis

- Gradalis

- Sirnaomics

- Silenseed

Market segment by Type, the product can be split into

- siRNA

- miRNA

- shRNA

Market segment by Application, split into

- Cancer

- Cardiovascular

- HBV

- Other

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global RNAi for Therapeutic status, future forecast, growth opportunity, key market and key players.

- To present the RNAi for Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of RNAi for Therapeutic are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global RNAi for Therapeutic Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNAi for Therapeutic Revenue
1.4 Market Analysis by Type
1.4.1 Global RNAi for Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 siRNA
1.4.3 miRNA
1.4.4 shRNA
1.5 Market by Application
1.5.1 Global RNAi for Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Cardiovascular
1.5.4 HBV
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 RNAi for Therapeutic Market Perspective (2015-2026)
2.2 RNAi for Therapeutic Growth Trends by Regions
2.2.1 RNAi for Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 RNAi for Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 RNAi for Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 RNAi for Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key RNAi for Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top RNAi for Therapeutic Players by Market Size
3.1.1 Global Top RNAi for Therapeutic Players by Revenue (2015-2020)
3.1.2 Global RNAi for Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNAi for Therapeutic Market Concentration Ratio
3.2.1 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by RNAi for Therapeutic Revenue in 2019
3.3 RNAi for Therapeutic Key Players Head office and Area Served
3.4 Key Players RNAi for Therapeutic Product Solution and Service
3.5 Date of Enter into RNAi for Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global RNAi for Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global RNAi for Therapeutic Forecasted Market Size by Type (2021-2026)
5 RNAi for Therapeutic Breakdown Data by Application (2015-2026)
5.1 Global RNAi for Therapeutic Market Size by Application (2015-2020)
5.2 Global RNAi for Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America RNAi for Therapeutic Market Size (2015-2020)
6.2 RNAi for Therapeutic Key Players in North America (2019-2020)
6.3 North America RNAi for Therapeutic Market Size by Type (2015-2020)
6.4 North America RNAi for Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe RNAi for Therapeutic Market Size (2015-2020)
7.2 RNAi for Therapeutic Key Players in Europe (2019-2020)
7.3 Europe RNAi for Therapeutic Market Size by Type (2015-2020)
7.4 Europe RNAi for Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China RNAi for Therapeutic Market Size (2015-2020)
8.2 RNAi for Therapeutic Key Players in China (2019-2020)
8.3 China RNAi for Therapeutic Market Size by Type (2015-2020)
8.4 China RNAi for Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan RNAi for Therapeutic Market Size (2015-2020)
9.2 RNAi for Therapeutic Key Players in Japan (2019-2020)
9.3 Japan RNAi for Therapeutic Market Size by Type (2015-2020)
9.4 Japan RNAi for Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia RNAi for Therapeutic Market Size (2015-2020)
10.2 RNAi for Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia RNAi for Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia RNAi for Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India RNAi for Therapeutic Market Size (2015-2020)
11.2 RNAi for Therapeutic Key Players in India (2019-2020)
11.3 India RNAi for Therapeutic Market Size by Type (2015-2020)
11.4 India RNAi for Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America RNAi for Therapeutic Market Size (2015-2020)
12.2 RNAi for Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America RNAi for Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America RNAi for Therapeutic Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Alnylam Pharmaceuticals
13.1.1 Alnylam Pharmaceuticals Company Details
13.1.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
13.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Introduction
13.1.4 Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020))
13.1.5 Alnylam Pharmaceuticals Recent Development
13.2 Arbutus Biopharma (Tekmira)
13.2.1 Arbutus Biopharma (Tekmira) Company Details
13.2.2 Arbutus Biopharma (Tekmira) Business Overview and Its Total Revenue
13.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Introduction
13.2.4 Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2015-2020)
13.2.5 Arbutus Biopharma (Tekmira) Recent Development
13.3 Arrowhead
13.3.1 Arrowhead Company Details
13.3.2 Arrowhead Business Overview and Its Total Revenue
13.3.3 Arrowhead RNAi for Therapeutic Introduction
13.3.4 Arrowhead Revenue in RNAi for Therapeutic Business (2015-2020)
13.3.5 Arrowhead Recent Development
13.4 Dicerna Pharmaceuticals
13.4.1 Dicerna Pharmaceuticals Company Details
13.4.2 Dicerna Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Introduction
13.4.4 Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020)
13.4.5 Dicerna Pharmaceuticals Recent Development
13.5 Mirna Therapeutics
13.5.1 Mirna Therapeutics Company Details
13.5.2 Mirna Therapeutics Business Overview and Its Total Revenue
13.5.3 Mirna Therapeutics RNAi for Therapeutic Introduction
13.5.4 Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020)
13.5.5 Mirna Therapeutics Recent Development
13.6 Quark Pharmaceuticals
13.6.1 Quark Pharmaceuticals Company Details
13.6.2 Quark Pharmaceuticals Business Overview and Its Total Revenue
13.6.3 Quark Pharmaceuticals RNAi for Therapeutic Introduction
13.6.4 Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020)
13.6.5 Quark Pharmaceuticals Recent Development
13.7 RXi Pharmaceuticals
13.7.1 RXi Pharmaceuticals Company Details
13.7.2 RXi Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 RXi Pharmaceuticals RNAi for Therapeutic Introduction
13.7.4 RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020)
13.7.5 RXi Pharmaceuticals Recent Development
13.8 Silence Therapeutics
13.8.1 Silence Therapeutics Company Details
13.8.2 Silence Therapeutics Business Overview and Its Total Revenue
13.8.3 Silence Therapeutics RNAi for Therapeutic Introduction
13.8.4 Silence Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020)
13.8.5 Silence Therapeutics Recent Development
13.9 Benitec Biopharma
13.9.1 Benitec Biopharma Company Details
13.9.2 Benitec Biopharma Business Overview and Its Total Revenue
13.9.3 Benitec Biopharma RNAi for Therapeutic Introduction
13.9.4 Benitec Biopharma Revenue in RNAi for Therapeutic Business (2015-2020)
13.9.5 Benitec Biopharma Recent Development
13.10 miRagen Therapeutics
13.10.1 miRagen Therapeutics Company Details
13.10.2 miRagen Therapeutics Business Overview and Its Total Revenue
13.10.3 miRagen Therapeutics RNAi for Therapeutic Introduction
13.10.4 miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020)
13.10.5 miRagen Therapeutics Recent Development
13.11 Sylentis
10.11.1 Sylentis Company Details
10.11.2 Sylentis Business Overview and Its Total Revenue
10.11.3 Sylentis RNAi for Therapeutic Introduction
10.11.4 Sylentis Revenue in RNAi for Therapeutic Business (2015-2020)
10.11.5 Sylentis Recent Development
13.12 Gradalis
10.12.1 Gradalis Company Details
10.12.2 Gradalis Business Overview and Its Total Revenue
10.12.3 Gradalis RNAi for Therapeutic Introduction
10.12.4 Gradalis Revenue in RNAi for Therapeutic Business (2015-2020)
10.12.5 Gradalis Recent Development
13.13 Sirnaomics
10.13.1 Sirnaomics Company Details
10.13.2 Sirnaomics Business Overview and Its Total Revenue
10.13.3 Sirnaomics RNAi for Therapeutic Introduction
10.13.4 Sirnaomics Revenue in RNAi for Therapeutic Business (2015-2020)
10.13.5 Sirnaomics Recent Development
13.14 Silenseed
10.14.1 Silenseed Company Details
10.14.2 Silenseed Business Overview and Its Total Revenue
10.14.3 Silenseed RNAi for Therapeutic Introduction
10.14.4 Silenseed Revenue in RNAi for Therapeutic Business (2015-2020)
10.14.5 Silenseed Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. RNAi for Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by RNAi for Therapeutic Revenue
Table 3. Ranking of Global Top RNAi for Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global RNAi for Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of siRNA
Table 6. Key Players of miRNA
Table 7. Key Players of shRNA
Table 8. Global RNAi for Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global RNAi for Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global RNAi for Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global RNAi for Therapeutic Market Share by Regions (2015-2020)
Table 12. Global RNAi for Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global RNAi for Therapeutic Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. RNAi for Therapeutic Market Growth Strategy
Table 18. Main Points Interviewed from Key RNAi for Therapeutic Players
Table 19. Global RNAi for Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 20. Global RNAi for Therapeutic Market Share by Players (2015-2020)
Table 21. Global Top RNAi for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi for Therapeutic as of 2019)
Table 22. Global RNAi for Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players RNAi for Therapeutic Product Solution and Service
Table 25. Date of Enter into RNAi for Therapeutic Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 28. Global RNAi for Therapeutic Market Size Share by Type (2015-2020)
Table 29. Global RNAi for Therapeutic Revenue Market Share by Type (2021-2026)
Table 30. Global RNAi for Therapeutic Market Size Share by Application (2015-2020)
Table 31. Global RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 32. Global RNAi for Therapeutic Market Size Share by Application (2021-2026)
Table 33. North America Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 34. North America Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 35. North America RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 36. North America RNAi for Therapeutic Market Share by Type (2015-2020)
Table 37. North America RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 38. North America RNAi for Therapeutic Market Share by Application (2015-2020)
Table 39. Europe Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 41. Europe RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 42. Europe RNAi for Therapeutic Market Share by Type (2015-2020)
Table 43. Europe RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 44. Europe RNAi for Therapeutic Market Share by Application (2015-2020)
Table 45. China Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 46. China Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 47. China RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 48. China RNAi for Therapeutic Market Share by Type (2015-2020)
Table 49. China RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 50. China RNAi for Therapeutic Market Share by Application (2015-2020)
Table 51. Japan Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 53. Japan RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 54. Japan RNAi for Therapeutic Market Share by Type (2015-2020)
Table 55. Japan RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 56. Japan RNAi for Therapeutic Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 59. Southeast Asia RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia RNAi for Therapeutic Market Share by Type (2015-2020)
Table 61. Southeast Asia RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia RNAi for Therapeutic Market Share by Application (2015-2020)
Table 63. India Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 64. India Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 65. India RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 66. India RNAi for Therapeutic Market Share by Type (2015-2020)
Table 67. India RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 68. India RNAi for Therapeutic Market Share by Application (2015-2020)
Table 69. Central & South America Key Players RNAi for Therapeutic Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players RNAi for Therapeutic Market Share (2019-2020)
Table 71. Central & South America RNAi for Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America RNAi for Therapeutic Market Share by Type (2015-2020)
Table 73. Central & South America RNAi for Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America RNAi for Therapeutic Market Share by Application (2015-2020)
Table 75. Alnylam Pharmaceuticals Company Details
Table 76. Alnylam Pharmaceuticals Business Overview
Table 77. Alnylam Pharmaceuticals Product
Table 78. Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 79. Alnylam Pharmaceuticals Recent Development
Table 80. Arbutus Biopharma (Tekmira) Company Details
Table 81. Arbutus Biopharma (Tekmira) Business Overview
Table 82. Arbutus Biopharma (Tekmira) Product
Table 83. Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 84. Arbutus Biopharma (Tekmira) Recent Development
Table 85. Arrowhead Company Details
Table 86. Arrowhead Business Overview
Table 87. Arrowhead Product
Table 88. Arrowhead Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 89. Arrowhead Recent Development
Table 90. Dicerna Pharmaceuticals Company Details
Table 91. Dicerna Pharmaceuticals Business Overview
Table 92. Dicerna Pharmaceuticals Product
Table 93. Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 94. Dicerna Pharmaceuticals Recent Development
Table 95. Mirna Therapeutics Company Details
Table 96. Mirna Therapeutics Business Overview
Table 97. Mirna Therapeutics Product
Table 98. Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 99. Mirna Therapeutics Recent Development
Table 100. Quark Pharmaceuticals Company Details
Table 101. Quark Pharmaceuticals Business Overview
Table 102. Quark Pharmaceuticals Product
Table 103. Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 104. Quark Pharmaceuticals Recent Development
Table 105. RXi Pharmaceuticals Company Details
Table 106. RXi Pharmaceuticals Business Overview
Table 107. RXi Pharmaceuticals Product
Table 108. RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 109. RXi Pharmaceuticals Recent Development
Table 110. Silence Therapeutics Business Overview
Table 111. Silence Therapeutics Product
Table 112. Silence Therapeutics Company Details
Table 113. Silence Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 114. Silence Therapeutics Recent Development
Table 115. Benitec Biopharma Company Details
Table 116. Benitec Biopharma Business Overview
Table 117. Benitec Biopharma Product
Table 118. Benitec Biopharma Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 119. Benitec Biopharma Recent Development
Table 120. miRagen Therapeutics Company Details
Table 121. miRagen Therapeutics Business Overview
Table 122. miRagen Therapeutics Product
Table 123. miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 124. miRagen Therapeutics Recent Development
Table 125. Sylentis Company Details
Table 126. Sylentis Business Overview
Table 127. Sylentis Product
Table 128. Sylentis Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 129. Sylentis Recent Development
Table 130. Gradalis Company Details
Table 131. Gradalis Business Overview
Table 132. Gradalis Product
Table 133. Gradalis Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 134. Gradalis Recent Development
Table 135. Sirnaomics Company Details
Table 136. Sirnaomics Business Overview
Table 137. Sirnaomics Product
Table 138. Sirnaomics Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 139. Sirnaomics Recent Development
Table 140. Silenseed Company Details
Table 141. Silenseed Business Overview
Table 142. Silenseed Product
Table 143. Silenseed Revenue in RNAi for Therapeutic Business (2015-2020) (Million US$)
Table 144. Silenseed Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi for Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. siRNA Features
Figure 3. miRNA Features
Figure 4. shRNA Features
Figure 5. Global RNAi for Therapeutic Market Share by Application: 2020 VS 2026
Figure 6. Cancer Case Studies
Figure 7. Cardiovascular Case Studies
Figure 8. HBV Case Studies
Figure 9. Other Case Studies
Figure 10. RNAi for Therapeutic Report Years Considered
Figure 11. Global RNAi for Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global RNAi for Therapeutic Market Share by Regions: 2020 VS 2026
Figure 13. Global RNAi for Therapeutic Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global RNAi for Therapeutic Market Share by Players in 2019
Figure 16. Global Top RNAi for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi for Therapeutic as of 2019
Figure 17. The Top 10 and 5 Players Market Share by RNAi for Therapeutic Revenue in 2019
Figure 18. North America RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America RNAi for Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 27. Arbutus Biopharma (Tekmira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Arbutus Biopharma (Tekmira) Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 29. Arrowhead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Arrowhead Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 31. Dicerna Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Dicerna Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 33. Mirna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Mirna Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 35. Quark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Quark Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 37. RXi Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. RXi Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 39. Silence Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Silence Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 41. Benitec Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Benitec Biopharma Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 43. miRagen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. miRagen Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 45. Sylentis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Sylentis Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 47. Gradalis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Gradalis Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 49. Sirnaomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sirnaomics Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 51. Silenseed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Silenseed Revenue Growth Rate in RNAi for Therapeutic Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Antisense and RNAi Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
    Published: 24-Feb-2020        Price: US 3480 Onwards        Pages: 103
    Market Overview The global Antisense and RNAi Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antisense and RNAi Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive......
  • Global Targeted RNA Sequencing Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 23-Feb-2020        Price: US 2980 Onwards        Pages: 84
    Snapshot The global Targeted RNA Sequencing market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Targeted RNA Sequencing by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Global RNAi for Therapeutic Market Data Survey Report 2015-2025
    Published: 11-Feb-2020        Price: US 1500 Onwards        Pages: 61
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • RNAi Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 147
    RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNAi Therape......
  • RNAi for Therapeutic Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 09-Feb-2020        Price: US 3000 Onwards        Pages: 148
    RNAi for Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNAi for Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNAi for Therapeutic manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese RNA......
  • Antisense and RNAI Therapeutics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 06-Feb-2020        Price: US 3000 Onwards        Pages: 143
    Antisense and RNAi Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Antisense and RNAi Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Antisense and RNAi Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of ......
  • Global RNAi for Therapeutic Market Growth (Status and Outlook) 2020-2025
    Published: 21-Jan-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach $ 3515.2 million by 2025, from $ 1488.6 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3. This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by type......
  • Global RNAi for Therapeutic Market Analysis 2015-2019 and Forecast 2020-2025
    Published: 16-Jan-2020        Price: US 2980 Onwards        Pages: 83
    Snapshot RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and b......
  • Global Targeted RNA Sequencing Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types. Targeted RNA-sequ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs